1. Gilmour, BC, Gudmundsrud, R, Frank, J, Hov, A, Lautrup, S, Aman, Y, Røsjø, H, Brenner, C, Ziegler, M, Tysnes, OB, Tzoulis, C, Omland, T, Søraas, A, Holmøy, T, Bergersen, LH, Storm-Mathisen, J, Nilsen, H, Fang, EF. Targeting NAD+ in translational research to relieve diseases and conditions of metabolic stress and ageing. Mech. Ageing Dev. 2020;186 :111208. doi: 10.1016/j.mad.2020.111208. PubMed PMID:31953124 .
  2. Sundal, C, Carmona, S, Yhr, M, Almström, O, Ljungberg, M, Hardy, J, Hedberg-Oldfors, C, Fred, Å, Brás, J, Oldfors, A, Andersen, O, Guerreiro, R. An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids. Acta Neuropathol Commun. 2019;7 (1):188. doi: 10.1186/s40478-019-0843-y. PubMed PMID:31775912 PubMed Central PMC6880494.
  3. Osuagwu, N, Dölle, C, Tzoulis, C. Poly-ADP-ribose assisted protein localization resolves that DJ-1, but not LRRK2 or α-synuclein, is localized to the mitochondrial matrix. PLoS ONE. 2019;14 (7):e0219909. doi: 10.1371/journal.pone.0219909. PubMed PMID:31323073 PubMed Central PMC6641658.
  4. Truong, GT, Park, SH, Choi, KK. Tensile Behaviors of Lap-Spliced Carbon Fiber-Textile Reinforced Mortar Composites Exposed to High Temperature. Materials (Basel). 2019;12 (9):. doi: 10.3390/ma12091512. PubMed PMID:31075851 PubMed Central PMC6539627.
  5. Sundal, C, Axelsson, M, Wiklund, L, Lindberg, C, Andersen, O. A SCA7 premutation may be a novel Mendelian modifier of MS course: A case report. Mult Scler Relat Disord. 2019;31 :148-150. doi: 10.1016/j.msard.2019.04.009. PubMed PMID:30999137 .
  6. Han, L, Madan, V, Mayakonda, A, Dakle, P, Woon, TW, Shyamsunder, P, Nordin, HBM, Cao, Z, Sundaresan, J, Lei, I, Wang, Z, Koeffler, HP. Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice. Leukemia. 2019;33 (9):2291-2305. doi: 10.1038/s41375-019-0438-4. PubMed PMID:30858552 PubMed Central PMC6756219.
  7. Bhatt, PS, Tzoulis, C, Balafkan, N, Miletic, H, Tran, GTT, Sanaker, PS, Bindoff, LA. Mitochondrial DNA depletion in sporadic inclusion body myositis. Neuromuscul. Disord. 2019;29 (3):242-246. doi: 10.1016/j.nmd.2019.02.001. PubMed PMID:30850168 .
  8. Demarest, TG, Truong, GTD, Lovett, J, Mohanty, JG, Mattison, JA, Mattson, MP, Ferrucci, L, Bohr, VA, Moaddel, R. Assessment of NAD+metabolism in human cell cultures, erythrocytes, cerebrospinal fluid and primate skeletal muscle. Anal. Biochem. 2019;572 :1-8. doi: 10.1016/j.ab.2019.02.019. PubMed PMID:30822397 PubMed Central PMC6685425.
  9. Desjardins, M, Arjunaraja, S, Stinson, JR, Dorjbal, B, Sundaresan, J, Niemela, J, Raffeld, M, Matthews, HF, Wang, A, Angelus, P, Su, HC, Mazer, BD, Snow, AL. A Unique Heterozygous CARD11 Mutation Combines Pathogenic Features of Both Gain- and Loss-of-Function Patients in a Four-Generation Family. Front Immunol. 2018;9 :2944. doi: 10.3389/fimmu.2018.02944. PubMed PMID:30619304 PubMed Central PMC6299974.
  10. Gaare, JJ, Nido, GS, Sztromwasser, P, Knappskog, PM, Dahl, O, Lund-Johansen, M, Maple-Grødem, J, Alves, G, Tysnes, OB, Johansson, S, Haugarvoll, K, Tzoulis, C. Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease. Mov. Disord. 2018;33 (10):1591-1600. doi: 10.1002/mds.64. PubMed PMID:30256453 PubMed Central PMC6282592.
  11. Hikmat, O, Tzoulis, C, Chong, WK, Chentouf, L, Klingenberg, C, Fratter, C, Carr, LJ, Prabhakar, P, Kumaraguru, N, Gissen, P, Cross, JH, Jacques, TS, Taanman, JW, Bindoff, LA, Rahman, S. Correction: The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genet. Med. 2019;21 (4):1027. doi: 10.1038/s41436-018-0098-1. PubMed PMID:30228318 .
  12. Schweizer, P, Dolle, C, Spiecker, E. In situ manipulation and switching of dislocations in bilayer graphene. Sci Adv. 2018;4 (8):eaat4712. doi: 10.1126/sciadv.aat4712. PubMed PMID:30105305 PubMed Central PMC6086622.
  13. Madan, V, Han, L, Hattori, N, Teoh, WW, Mayakonda, A, Sun, QY, Ding, LW, Nordin, HBM, Lim, SL, Shyamsunder, P, Dakle, P, Sundaresan, J, Doan, NB, Sanada, M, Sato-Otsubo, A, Meggendorfer, M, Yang, H, Said, JW, Ogawa, S, Haferlach, T, Liang, DC, Shih, LY, Nakamaki, T, Wang, QT, Koeffler, HP. ASXL2 regulates hematopoiesis in mice and its deficiency promotes myeloid expansion. Haematologica. 2018;103 (12):1980-1990. doi: 10.3324/haematol.2018.189928. PubMed PMID:30093396 PubMed Central PMC6269306.
  14. Lunde, KA, Chung, J, Dalen, I, Pedersen, KF, Linder, J, Domellöf, ME, Elgh, E, Macleod, AD, Tzoulis, C, Larsen, JP, Tysnes, OB, Forsgren, L, Counsell, CE, Alves, G, Maple-Grødem, J. Association of glucocerebrosidase polymorphisms and mutations with dementia in incident Parkinson's disease. Alzheimers Dement. 2018;14 (10):1293-1301. doi: 10.1016/j.jalz.2018.04.006. PubMed PMID:29792872 .
  15. Sundal, C, Tedroff, J. Lakartidningen. 2018;115 :. . PubMed PMID:29762814 .
  16. Flønes, IH, Tzoulis, C. Movement disorders in mitochondrial disease: a clinicopathological correlation. Curr. Opin. Neurol. 2018;31 (4):472-483. doi: 10.1097/WCO.0000000000000583. PubMed PMID:29750731 .
  17. Brakedal, B. Tidsskr. Nor. Laegeforen. 2018;138 (7):. doi: 10.4045/tidsskr.18.0002. PubMed PMID:29663779 .
  18. Maple-Grødem, J, Chung, J, Lunde, KA, Tzoulis, C, Tysnes, OB, Pedersen, KF, Alves, G. Alzheimer disease associated variants in SORL1 accelerate dementia development in Parkinson disease. Neurosci. Lett. 2018;674 :123-126. doi: 10.1016/j.neulet.2018.03.036. PubMed PMID:29567423 .
  19. Erga, AH, Dalen, I, Ushakova, A, Chung, J, Tzoulis, C, Tysnes, OB, Alves, G, Pedersen, KF, Maple-Grødem, J. Dopaminergic and Opioid Pathways Associated with Impulse Control Disorders in Parkinson's Disease. Front Neurol. 2018;9 :109. doi: 10.3389/fneur.2018.00109. PubMed PMID:29541058 PubMed Central PMC5835501.
  20. Buonvicino, D, Mazzola, F, Zamporlini, F, Resta, F, Ranieri, G, Camaioni, E, Muzzi, M, Zecchi, R, Pieraccini, G, Dölle, C, Calamante, M, Bartolucci, G, Ziegler, M, Stecca, B, Raffaelli, N, Chiarugi, A. Identification of the Nicotinamide Salvage Pathway as a New Toxification Route for Antimetabolites. Cell Chem Biol. 2018;25 (4):471-482.e7. doi: 10.1016/j.chembiol.2018.01.012. PubMed PMID:29478906 .
  21. Stige, KE, Gjerde, IO, Houge, G, Knappskog, PM, Tzoulis, C. Beta-propeller protein-associated neurodegeneration: a case report and review of the literature. Clin Case Rep. 2018;6 (2):353-362. doi: 10.1002/ccr3.1358. PubMed PMID:29445477 PubMed Central PMC5799652.
  22. Schirowski, M, Abellán, G, Nuin, E, Pampel, J, Dolle, C, Wedler, V, Fellinger, TP, Spiecker, E, Hauke, F, Hirsch, A. Fundamental Insights into the Reductive Covalent Cross-Linking of Single-Walled Carbon Nanotubes. J. Am. Chem. Soc. 2018;140 (9):3352-3360. doi: 10.1021/jacs.7b12910. PubMed PMID:29405064 .
  23. Gaare, JJ, Nido, GS, Sztromwasser, P, Knappskog, PM, Dahl, O, Lund-Johansen, M, Alves, G, Tysnes, OB, Johansson, S, Haugarvoll, K, Tzoulis, C. No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson's disease. Brain. 2018;141 (3):e16. doi: 10.1093/brain/awx378. PubMed PMID:29373637 PubMed Central PMC5837630.
  24. Dölle, C, Bindoff, LA, Tzoulis, C. 3,3'-Diaminobenzidine staining interferes with PCR-based DNA analysis. Sci Rep. 2018;8 (1):1272. doi: 10.1038/s41598-018-19745-9. PubMed PMID:29352159 PubMed Central PMC5775208.
  25. Flønes, IH, Fernandez-Vizarra, E, Lykouri, M, Brakedal, B, Skeie, GO, Miletic, H, Lilleng, PK, Alves, G, Tysnes, OB, Haugarvoll, K, Dölle, C, Zeviani, M, Tzoulis, C. Neuronal complex I deficiency occurs throughout the Parkinson's disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathol. 2018;135 (3):409-425. doi: 10.1007/s00401-017-1794-7. PubMed PMID:29270838 .
  26. Nido, GS, Dölle, C, Flønes, I, Tuppen, HA, Alves, G, Tysnes, OB, Haugarvoll, K, Tzoulis, C. Ultradeep mapping of neuronal mitochondrial deletions in Parkinson's disease. Neurobiol. Aging. 2018;63 :120-127. doi: 10.1016/j.neurobiolaging.2017.10.024. PubMed PMID:29257976 .
  27. Villaseñor, R, Schilling, M, Sundaresan, J, Lutz, Y, Collin, L. Sorting Tubules Regulate Blood-Brain Barrier Transcytosis. Cell Rep. 2017;21 (11):3256-3270. doi: 10.1016/j.celrep.2017.11.055. PubMed PMID:29241551 .
  28. Dölle, C, Ziegler, M. ADP-ribosylation of DNA moving into focus. FEBS J. 2017;284 (23):3999-4001. doi: 10.1111/febs.14326. PubMed PMID:29205912 .
  29. Sofou, K, de Coo, IFM, Ostergaard, E, Isohanni, P, Naess, K, De Meirleir, L, Tzoulis, C, Uusimaa, J, Lönnqvist, T, Bindoff, LA, Tulinius, M, Darin, N. Phenotype-genotype correlations in Leigh syndrome: new insights from a multicentre study of 96 patients. J. Med. Genet. 2018;55 (1):21-27. doi: 10.1136/jmedgenet-2017-104891. PubMed PMID:29101127 .
  30. Hikmat, O, Tzoulis, C, Klingenberg, C, Rasmussen, M, Tallaksen, CME, Brodtkorb, E, Fiskerstrand, T, McFarland, R, Rahman, S, Bindoff, LA. Erratum to: The presence of anaemia negatively influences survival in patients with POLG disease. J. Inherit. Metab. Dis. 2018;41 (1):153. doi: 10.1007/s10545-017-0092-9. PubMed PMID:28952135 .
  31. Hwang, J, Kim, H, Truong, GV, Xuan, J, Hasenberg, T, Kang, HW. Dual-wavelength-assisted thermal hemostasis for treatment of benign prostate hyperplasia. J Biophotonics. 2018;11 (4):e201700192. doi: 10.1002/jbio.201700192. PubMed PMID:28926200 .
  32. Hikmat, O, Tzoulis, C, Klingenberg, C, Rasmussen, M, Tallaksen, CME, Brodtkorb, E, Fiskerstrand, T, McFarland, R, Rahman, S, Bindoff, LA. The presence of anaemia negatively influences survival in patients with POLG disease. J. Inherit. Metab. Dis. 2017;40 (6):861-866. doi: 10.1007/s10545-017-0084-9. PubMed PMID:28865037 .
  33. Brakedal, B, Flønes, I, Reiter, SF, Torkildsen, Ø, Dölle, C, Assmus, J, Haugarvoll, K, Tzoulis, C. Glitazone use associated with reduced risk of Parkinson's disease. Mov. Disord. 2017;32 (11):1594-1599. doi: 10.1002/mds.27128. PubMed PMID:28861893 PubMed Central PMC5697685.
  34. Hikmat, O, Eichele, T, Tzoulis, C, Bindoff, LA. Understanding the Epilepsy in POLG Related Disease. Int J Mol Sci. 2017;18 (9):. doi: 10.3390/ijms18091845. PubMed PMID:28837072 PubMed Central PMC5618494.
  35. VanLinden, MR, Niere, M, Nikiforov, AA, Ziegler, M, Dölle, C. Compartment-Specific Poly-ADP-Ribose Formation as a Biosensor for Subcellular NAD Pools. Methods Mol. Biol. 2017;1608 :45-56. doi: 10.1007/978-1-4939-6993-7_4. PubMed PMID:28695502 .
  36. Guida, C, Stephen, S, Guitton, R, Ramracheya, RD. The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes. Trends Endocrinol. Metab. 2017;28 (8):626-636. doi: 10.1016/j.tem.2017.04.005. PubMed PMID:28533020 .
  37. Hikmat, O, Tzoulis, C, Chong, WK, Chentouf, L, Klingenberg, C, Fratter, C, Carr, LJ, Prabhakar, P, Kumaraguru, N, Gissen, P, Cross, JH, Jacques, TS, Taanman, JW, Bindoff, LA, Rahman, S. The clinical spectrum and natural history of early-onset diseases due to DNA polymerase gamma mutations. Genet. Med. 2017;19 (11):1217-1225. doi: 10.1038/gim.2017.35. PubMed PMID:28471437 .
  38. Pakdaman, Y, Sanchez-Guixé, M, Kleppe, R, Erdal, S, Bustad, HJ, Bjørkhaug, L, Haugarvoll, K, Tzoulis, C, Heimdal, K, Knappskog, PM, Johansson, S, Aukrust, I. In vitro characterization of six STUB1 variants in spinocerebellar ataxia 16 reveals altered structural properties for the encoded CHIP proteins. Biosci. Rep. 2017;37 (2):. doi: 10.1042/BSR20170251. PubMed PMID:28396517 PubMed Central PMC5408658.
  39. Varhaug, KN, Vedeler, CA, Tzoulis, C, Bindoff, LA. [Multiple sclerosis - a mitochondria-mediated disease?]. Tidsskr. Nor. Laegeforen. 2017;137 (4):284-287. doi: 10.4045/tidsskr.16.0210. PubMed PMID:28225235 .
  40. Haugarvoll, K, Johansson, S, Rodriguez, CE, Boman, H, Haukanes, BI, Bruland, O, Roque, F, Jonassen, I, Blomqvist, M, Telstad, W, Månsson, JE, Knappskog, PM, Bindoff, LA. GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies. PLoS ONE. 2017;12 (1):e0169309. doi: 10.1371/journal.pone.0169309. PubMed PMID:28052128 PubMed Central PMC5215700.
  41. Brakedal, B, Haugarvoll, K, Tzoulis, C. Simvastatin is associated with decreased risk of Parkinson disease. Ann. Neurol. 2017;81 (2):329-330. doi: 10.1002/ana.24857. PubMed PMID:28019662 .
  42. Varhaug, KN, Vedeler, CA, Myhr, KM, Aarseth, JH, Tzoulis, C, Bindoff, LA. Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis. Mitochondrion. 2017;34 :32-35. doi: 10.1016/j.mito.2016.12.003. PubMed PMID:28017684 .
  43. Dölle, C, Flønes, I, Nido, GS, Miletic, H, Osuagwu, N, Kristoffersen, S, Lilleng, PK, Larsen, JP, Tysnes, OB, Haugarvoll, K, Bindoff, LA, Tzoulis, C. Defective mitochondrial DNA homeostasis in the substantia nigra in Parkinson disease. Nat Commun. 2016;7 :13548. doi: 10.1038/ncomms13548. PubMed PMID:27874000 PubMed Central PMC5121427.
  44. Butz, B, Dolle, C, Halbig, CE, Spiecker, E, Eigler, S. Highly Intact and Pure Oxo-Functionalized Graphene: Synthesis and Electron-Beam-Induced Reduction. Angew. Chem. Int. Ed. Engl. 2016;55 (51):15771-15774. doi: 10.1002/anie.201608377. PubMed PMID:27865029 .
  45. Gaare, JJ, Skeie, GO, Tzoulis, C, Larsen, JP, Tysnes, OB. Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. Mov. Disord. 2017;32 (2):241-245. doi: 10.1002/mds.26856. PubMed PMID:27862270 .
  46. Tzoulis, C, Henriksen, E, Miletic, H, Bindoff, LA. No evidence of ischemia in stroke-like lesions of mitochondrial POLG encephalopathy. Mitochondrion. 2017;32 :10-15. doi: 10.1016/j.mito.2016.11.004. PubMed PMID:27838477 .
  47. Abdullah, R, Patil, KS, Rosen, B, Pal, R, Prabhudesai, S, Lee, S, Basak, I, Hoedt, E, Yang, P, Panick, K, Ho, HP, Chang, E, Tzoulis, C, Larsen, JP, Neubert, TA, Alves, G, Møller, SG. Subcellular Parkinson's Disease-Specific Alpha-Synuclein Species Show Altered Behavior in Neurodegeneration. Mol. Neurobiol. 2017;54 (10):7639-7655. doi: 10.1007/s12035-016-0266-8. PubMed PMID:27837450 .
  48. Talasila, KM, Røsland, GV, Hagland, HR, Eskilsson, E, Flønes, IH, Fritah, S, Azuaje, F, Atai, N, Harter, PN, Mittelbronn, M, Andersen, M, Joseph, JV, Hossain, JA, Vallar, L, Noorden, CJ, Niclou, SP, Thorsen, F, Tronstad, KJ, Tzoulis, C, Bjerkvig, R, Miletic, H. The angiogenic switch leads to a metabolic shift in human glioblastoma. Neuro-oncology. 2017;19 (3):383-393. doi: 10.1093/neuonc/now175. PubMed PMID:27591677 PubMed Central PMC5464376.
  49. Tzoulis, C, Schwarzlmüller, T, Biermann, M, Haugarvoll, K, Bindoff, LA. Mitochondrial DNA homeostasis is essential for nigrostriatal integrity. Mitochondrion. 2016;28 :33-7. doi: 10.1016/j.mito.2016.03.003. PubMed PMID:26979109 .
  50. Flønes, I, Sztromwasser, P, Haugarvoll, K, Dölle, C, Lykouri, M, Schwarzlmüller, T, Jonassen, I, Miletic, H, Johansson, S, Knappskog, PM, Bindoff, LA, Tzoulis, C. Novel SLC19A3 Promoter Deletion and Allelic Silencing in Biotin-Thiamine-Responsive Basal Ganglia Encephalopathy. PLoS ONE. 2016;11 (2):e0149055. doi: 10.1371/journal.pone.0149055. PubMed PMID:26863430 PubMed Central PMC4749299.
  51. Haugarvoll, K, Bindoff, LA, Tzoulis, C. Nigrostriatal denervation sine parkinsonism. Brain. 2016;139 (Pt 4):e25. doi: 10.1093/brain/awv410. PubMed PMID:26811251 .
  52. Flønes, IH, Haugarvoll, K, Sundal, C, Tzoulis, C. A woman in her 70s with chronic walking difficulties. Tidsskr. Nor. Laegeforen. 2015;135 (19):1753-5. doi: 10.4045/tidsskr.15.0111. PubMed PMID:26486671 .
  53. VanLinden, MR, Dölle, C, Pettersen, IK, Kulikova, VA, Niere, M, Agrimi, G, Dyrstad, SE, Palmieri, F, Nikiforov, AA, Tronstad, KJ, Ziegler, M. Subcellular Distribution of NAD+ between Cytosol and Mitochondria Determines the Metabolic Profile of Human Cells. J. Biol. Chem. 2015;290 (46):27644-59. doi: 10.1074/jbc.M115.654129. PubMed PMID:26432643 PubMed Central PMC4646015.
  54. Kulikova, V, Shabalin, K, Nerinovski, K, Dölle, C, Niere, M, Yakimov, A, Redpath, P, Khodorkovskiy, M, Migaud, ME, Ziegler, M, Nikiforov, A. Generation, Release, and Uptake of the NAD Precursor Nicotinic Acid Riboside by Human Cells. J. Biol. Chem. 2015;290 (45):27124-37. doi: 10.1074/jbc.M115.664458. PubMed PMID:26385918 PubMed Central PMC4646395.
  55. Brakedal, B. [A clinician and a bayesian]. Tidsskr. Nor. Laegeforen. 2015;135 (16):1468-70. doi: 10.4045/tidsskr.15.0557. PubMed PMID:26356460 .
  56. Bjørk, MH, Gjerde, IO, Tzoulis, C, Ulvik, RJ, Bindoff, LA. A man in his 50s with high ferritin levels and increasing cognitive impairment. Tidsskr. Nor. Laegeforen. 2015;135 (15):1369-72. doi: 10.4045/tidsskr.14.1115. PubMed PMID:26315240 .
  57. Nido, GS, Ryan, MM, Benuskova, L, Williams, JM. Dynamical properties of gene regulatory networks involved in long-term potentiation. Front Mol Neurosci. 2015;8 :42. doi: 10.3389/fnmol.2015.00042. PubMed PMID:26300724 PubMed Central PMC4528166.
  58. Oftedal, BE, Hellesen, A, Erichsen, MM, Bratland, E, Vardi, A, Perheentupa, J, Kemp, EH, Fiskerstrand, T, Viken, MK, Weetman, AP, Fleishman, SJ, Banka, S, Newman, WG, Sewell, WA, Sozaeva, LS, Zayats, T, Haugarvoll, K, Orlova, EM, Haavik, J, Johansson, S, Knappskog, PM, Løvås, K, Wolff, AS, Abramson, J, Husebye, ES. Dominant Mutations in the Autoimmune Regulator AIRE Are Associated with Common Organ-Specific Autoimmune Diseases. Immunity. 2015;42 (6):1185-96. doi: 10.1016/j.immuni.2015.04.021. PubMed PMID:26084028 .
  59. Tzoulis, C, Schwarzlmüller, T, Gjerde, IO, Søfteland, E, Neckelmann, G, Biermann, M, Haroche, J, Straume, O, Vintermyr, OK. Excellent response of intramedullary Erdheim-Chester disease to vemurafenib: a case report. BMC Res Notes. 2015;8 :171. doi: 10.1186/s13104-015-1135-7. PubMed PMID:25926131 PubMed Central PMC4450489.
  60. Albanese, A, Abbruzzese, G, Dressler, D, Duzynski, W, Khatkova, S, Marti, MJ, Mir, P, Montecucco, C, Moro, E, Pinter, M, Relja, M, Roze, E, Skogseid, IM, Timerbaeva, S, Tzoulis, C. Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement. J. Neurol. 2015;262 (10):2201-13. doi: 10.1007/s00415-015-7703-x. PubMed PMID:25877834 PubMed Central PMC4608989.
  61. Tzoulis, C, Zayats, T, Knappskog, PM, Müller, B, Larsen, JP, Tysnes, OB, Bindoff, LA, Johansson, S, Haugarvoll, K. HTRA2 p.G399S in Parkinson disease, essential tremor, and tremulous cervical dystonia. Proc. Natl. Acad. Sci. U.S.A. 2015;112 (18):E2268. doi: 10.1073/pnas.1503105112. PubMed PMID:25825781 PubMed Central PMC4426452.
  62. Love, NR, Pollak, N, Dölle, C, Niere, M, Chen, Y, Oliveri, P, Amaya, E, Patel, S, Ziegler, M. NAD kinase controls animal NADP biosynthesis and is modulated via evolutionarily divergent calmodulin-dependent mechanisms. Proc. Natl. Acad. Sci. U.S.A. 2015;112 (5):1386-91. doi: 10.1073/pnas.1417290112. PubMed PMID:25605906 PubMed Central PMC4321265.
  63. Madan, V, Kanojia, D, Li, J, Okamoto, R, Sato-Otsubo, A, Kohlmann, A, Sanada, M, Grossmann, V, Sundaresan, J, Shiraishi, Y, Miyano, S, Thol, F, Ganser, A, Yang, H, Haferlach, T, Ogawa, S, Koeffler, HP. Aberrant splicing of U12-type introns is the hallmark of ZRSR2 mutant myelodysplastic syndrome. Nat Commun. 2015;6 :6042. doi: 10.1038/ncomms7042. PubMed PMID:25586593 PubMed Central PMC4349895.
  64. Strauss, V, Margraf, JT, Dolle, C, Butz, B, Nacken, TJ, Walter, J, Bauer, W, Peukert, W, Spiecker, E, Clark, T, Guldi, DM. Carbon nanodots: toward a comprehensive understanding of their photoluminescence. J. Am. Chem. Soc. 2014;136 (49):17308-16. doi: 10.1021/ja510183c. PubMed PMID:25372278 .
  65. Sundal, C, Baker, M, Karrenbauer, V, Gustavsen, M, Bedri, S, Glaser, A, Myhr, KM, Haugarvoll, K, Zetterberg, H, Harbo, H, Kockum, I, Hillert, J, Wszolek, Z, Rademakers, R, Andersen, O. Hereditary diffuse leukoencephalopathy with spheroids with phenotype of primary progressive multiple sclerosis. Eur. J. Neurol. 2015;22 (2):328-333. doi: 10.1111/ene.12572. PubMed PMID:25311247 PubMed Central PMC4289423.
  66. Sundal, C. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology. 2014;82 (20):1846. doi: 10.1212/WNL.0000000000000399. PubMed PMID:24843036 .
  67. Tzoulis, C, Tran, GT, Coxhead, J, Bertelsen, B, Lilleng, PK, Balafkan, N, Payne, B, Miletic, H, Chinnery, PF, Bindoff, LA. Molecular pathogenesis of polymerase γ-related neurodegeneration. Ann. Neurol. 2014;76 (1):66-81. doi: 10.1002/ana.24185. PubMed PMID:24841123 PubMed Central PMC4140551.
  68. Skoge, RH, Dölle, C, Ziegler, M. Regulation of SIRT2-dependent α-tubulin deacetylation by cellular NAD levels. DNA Repair (Amst.). 2014;23 :33-8. doi: 10.1016/j.dnarep.2014.04.011. PubMed PMID:24814981 .
  69. Sofou, K, De Coo, IF, Isohanni, P, Ostergaard, E, Naess, K, De Meirleir, L, Tzoulis, C, Uusimaa, J, De Angst, IB, Lönnqvist, T, Pihko, H, Mankinen, K, Bindoff, LA, Tulinius, M, Darin, N. A multicenter study on Leigh syndrome: disease course and predictors of survival. Orphanet J Rare Dis. 2014;9 :52. doi: 10.1186/1750-1172-9-52. PubMed PMID:24731534 PubMed Central PMC4021638.
  70. Brakedal, B, Tysnes, OB, Skeie, GO, Larsen, JP, Müller, B. The factor structure of the UPDRS motor scores changes during early Parkinson's disease. Parkinsonism Relat. Disord. 2014;20 (6):617-21. doi: 10.1016/j.parkreldis.2014.03.008. PubMed PMID:24685659 .
  71. Wedding, IM, Koht, J, Tran, GT, Misceo, D, Selmer, KK, Holmgren, A, Frengen, E, Bindoff, L, Tallaksen, CM, Tzoulis, C. Spastic paraplegia type 7 is associated with multiple mitochondrial DNA deletions. PLoS ONE. 2014;9 (1):e86340. doi: 10.1371/journal.pone.0086340. PubMed PMID:24466038 PubMed Central PMC3899233.
  72. Butz, B, Dolle, C, Niekiel, F, Weber, K, Waldmann, D, Weber, HB, Meyer, B, Spiecker, E. Dislocations in bilayer graphene. Nature. 2014;505 (7484):533-7. doi: 10.1038/nature12780. PubMed PMID:24352231 .
  73. Haugarvoll, K, Tzoulis, C, Tran, GT, Karlsen, B, Engelsen, BA, Knappskog, PM, Bindoff, LA. Myoclonus-dystonia and epilepsy in a family with a novel epsilon-sarcoglycan mutation. J. Neurol. 2014;261 (2):358-62. doi: 10.1007/s00415-013-7203-9. PubMed PMID:24297365 .
  74. Dölle, C, Skoge, RH, Vanlinden, MR, Ziegler, M. NAD biosynthesis in humans--enzymes, metabolites and therapeutic aspects. Curr Top Med Chem. 2013;13 (23):2907-17. doi: 10.2174/15680266113136660206. PubMed PMID:24171775 .
  75. Fujioka, S, Broderick, DF, Sundal, C, Baker, MC, Rademakers, R, Wszolek, ZK. An adult-onset leukoencephalopathy with axonal spheroids and pigmented glia accompanied by brain calcifications: a case report and a literature review of brain calcifications disorders. J. Neurol. 2013;260 (10):2665-8. doi: 10.1007/s00415-013-7093-x. PubMed PMID:24036850 PubMed Central PMC3865925.
  76. Sundal, C, Fujioka, S, Van Gerpen, JA, Wider, C, Nicholson, AM, Baker, M, Shuster, EA, Aasly, J, Spina, S, Ghetti, B, Roeber, S, Garbern, J, Tselis, A, Swerdlow, RH, Miller, BB, Borjesson-Hanson, A, Uitti, RJ, Ross, OA, Stoessl, AJ, Rademakers, R, Josephs, KA, Dickson, DW, Broderick, D, Wszolek, ZK. Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat. Disord. 2013;19 (10):869-77. doi: 10.1016/j.parkreldis.2013.05.013. PubMed PMID:23787135 PubMed Central PMC3977389.
  77. Tzoulis, C, Johansson, S, Haukanes, BI, Boman, H, Knappskog, PM, Bindoff, LA. Novel SACS mutations identified by whole exome sequencing in a norwegian family with autosomal recessive spastic ataxia of Charlevoix-Saguenay. PLoS ONE. 2013;8 (6):e66145. doi: 10.1371/journal.pone.0066145. PubMed PMID:23785480 PubMed Central PMC3681964.
  78. Sundal, C, Jönsson, L, Ljungberg, M, Zhong, J, Tian, W, Zhu, T, Linden, T, Börjesson-Hanson, A, Andersen, O, Ekholm, S. Different stages of white matter changes in the original HDLS family revealed by advanced MRI techniques. J Neuroimaging. ;24 (5):444-52. doi: 10.1111/jon.12037. PubMed PMID:23751174 .
  79. Tzoulis, C, Vedeler, C, Haugen, M, Storstein, A, Tran, GT, Gjerde, IO, Biermann, M, Schwarzlmüller, T, Bindoff, LA. Progressive striatal necrosis associated with anti-NMDA receptor antibodies. BMC Neurol. 2013;13 :55. doi: 10.1186/1471-2377-13-55. PubMed PMID:23725534 PubMed Central PMC3673874.
  80. Tzoulis, C, Tran, GT, Schwarzlmüller, T, Specht, K, Haugarvoll, K, Balafkan, N, Lilleng, PK, Miletic, H, Biermann, M, Bindoff, LA. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations. Brain. 2013;136 (Pt 8):2393-404. doi: 10.1093/brain/awt103. PubMed PMID:23625061 .
  81. Dölle, C, Rack, JG, Ziegler, M. NAD and ADP-ribose metabolism in mitochondria. FEBS J. 2013;280 (15):3530-41. doi: 10.1111/febs.12304. PubMed PMID:23617329 .
  82. Fujioka, S, Sundal, C, Wszolek, ZK. Autosomal dominant cerebellar ataxia type III: a review of the phenotypic and genotypic characteristics. Orphanet J Rare Dis. 2013;8 :14. doi: 10.1186/1750-1172-8-14. PubMed PMID:23331413 PubMed Central PMC3558377.
  83. Haugarvoll, K, Johansson, S, Tzoulis, C, Haukanes, BI, Bredrup, C, Neckelmann, G, Boman, H, Knappskog, PM, Bindoff, LA. MRI characterisation of adult onset alpha-methylacyl-coA racemase deficiency diagnosed by exome sequencing. Orphanet J Rare Dis. 2013;8 :1. doi: 10.1186/1750-1172-8-1. PubMed PMID:23286897 PubMed Central PMC3567975.
  84. Fujioka, S, Sundal, C, Strongosky, AJ, Castanedes, MC, Rademakers, R, Ross, OA, Vilariño-Güell, C, Farrer, MJ, Wszolek, ZK, Dickson, DW. Sequence variants in eukaryotic translation initiation factor 4-gamma (eIF4G1) are associated with Lewy body dementia. Acta Neuropathol. 2013;125 (3):425-38. doi: 10.1007/s00401-012-1059-4. PubMed PMID:23124435 PubMed Central PMC3580022.
  85. Tzoulis, C, Bindoff, LA. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain. 2012;135 (Pt 12):3627-34. doi: 10.1093/brain/aws223. PubMed PMID:23065482 .
  86. Fujioka, S, Rayaprolu, S, Sundal, C, Broderick, DF, Langley, WA, Shoffner, J, Hyams, LC, Rademakers, R, Graff-Radford, NR, Tatum, W, Ross, OA, Wszolek, ZK. A novel de novo pathogenic mutation in the CACNA1A gene. Mov. Disord. 2012;27 (12):1578-9. doi: 10.1002/mds.25198. PubMed PMID:23038654 PubMed Central PMC3477248.
  87. Chiarugi, A, Dölle, C, Felici, R, Ziegler, M. The NAD metabolome--a key determinant of cancer cell biology. Nat. Rev. Cancer. 2012;12 (11):741-52. doi: 10.1038/nrc3340. PubMed PMID:23018234 .
  88. Balafkan, N, Tzoulis, C, Müller, B, Haugarvoll, K, Tysnes, OB, Larsen, JP, Bindoff, LA. Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population. Mitochondrion. 2012;12 (6):640-3. doi: 10.1016/j.mito.2012.08.004. PubMed PMID:22963882 .
  89. Sundal, C, Van Gerpen, JA, Nicholson, AM, Wider, C, Shuster, EA, Aasly, J, Spina, S, Ghetti, B, Roeber, S, Garbern, J, Borjesson-Hanson, A, Tselis, A, Swerdlow, RH, Miller, BB, Fujioka, S, Heckman, MG, Uitti, RJ, Josephs, KA, Baker, M, Andersen, O, Rademakers, R, Dickson, DW, Broderick, D, Wszolek, ZK. MRI characteristics and scoring in HDLS due to CSF1R gene mutations. Neurology. 2012;79 (6):566-74. doi: 10.1212/WNL.0b013e318263575a. PubMed PMID:22843259 PubMed Central PMC3413763.
  90. Tzoulis, C, Gjerde, IO, Søfteland, E, Neckelmann, G, Strøm, E, Vintermyr, OK, Sviland, L, Biermann, M. Erdheim-Chester disease presenting with an intramedullary spinal cord lesion. J. Neurol. 2012;259 (10):2240-2. doi: 10.1007/s00415-012-6544-0. PubMed PMID:22638564 .
  91. Niere, M, Mashimo, M, Agledal, L, Dölle, C, Kasamatsu, A, Kato, J, Moss, J, Ziegler, M. ADP-ribosylhydrolase 3 (ARH3), not poly(ADP-ribose) glycohydrolase (PARG) isoforms, is responsible for degradation of mitochondrial matrix-associated poly(ADP-ribose). J. Biol. Chem. 2012;287 (20):16088-102. doi: 10.1074/jbc.M112.349183. PubMed PMID:22433848 PubMed Central PMC3351285.
  92. Rademakers, R, Baker, M, Nicholson, AM, Rutherford, NJ, Finch, N, Soto-Ortolaza, A, Lash, J, Wider, C, Wojtas, A, DeJesus-Hernandez, M, Adamson, J, Kouri, N, Sundal, C, Shuster, EA, Aasly, J, MacKenzie, J, Roeber, S, Kretzschmar, HA, Boeve, BF, Knopman, DS, Petersen, RC, Cairns, NJ, Ghetti, B, Spina, S, Garbern, J, Tselis, AC, Uitti, R, Das, P, Van Gerpen, JA, Meschia, JF, Levy, S, Broderick, DF, Graff-Radford, N, Ross, OA, Miller, BB, Swerdlow, RH, Dickson, DW, Wszolek, ZK. Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat. Genet. 2011;44 (2):200-5. doi: 10.1038/ng.1027. PubMed PMID:22197934 PubMed Central PMC3267847.
  93. Sundal, C, Fujioka, S, Uitti, RJ, Wszolek, ZK. Autosomal dominant Parkinson's disease. Parkinsonism Relat. Disord. 2012;18 Suppl 1 :S7-10. doi: 10.1016/S1353-8020(11)70005-0. PubMed PMID:22166459 .
  94. Sundal, C, Lash, J, Aasly, J, Øygarden, S, Roeber, S, Kretzschman, H, Garbern, JY, Tselis, A, Rademakers, R, Dickson, DW, Broderick, D, Wszolek, ZK. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J. Neurol. Sci. 2012;314 (1-2):130-7. doi: 10.1016/j.jns.2011.10.006. PubMed PMID:22050953 PubMed Central PMC3275663.
  95. Dolle, C, Magrone, P, Riva, S, Ambrosi, M, Fratini, E, Peruzzi, N, Lo Nostro, P. Symmetric and asymmetric bolaamphiphiles from ascorbic acid. J Phys Chem B. 2011;115 (40):11638-49. doi: 10.1021/jp204920y. PubMed PMID:21894932 .
  96. Tzoulis, C, Tran, GT, Gjerde, IO, Aasly, J, Neckelmann, G, Rydland, J, Varga, V, Wadel-Andersen, P, Bindoff, LA. Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J. Neurol. 2012;259 (2):292-6. doi: 10.1007/s00415-011-6176-9. PubMed PMID:21792730 .
  97. Eichele, T, Rachakonda, S, Brakedal, B, Eikeland, R, Calhoun, VD. EEGIFT: group independent component analysis for event-related EEG data. Comput Intell Neurosci. 2011;2011 :129365. doi: 10.1155/2011/129365. PubMed PMID:21747835 PubMed Central PMC3130967.
  98. Nikiforov, A, Dölle, C, Niere, M, Ziegler, M. Pathways and subcellular compartmentation of NAD biosynthesis in human cells: from entry of extracellular precursors to mitochondrial NAD generation. J. Biol. Chem. 2011;286 (24):21767-78. doi: 10.1074/jbc.M110.213298. PubMed PMID:21504897 PubMed Central PMC3122232.
  99. Haugarvoll, K, Bindoff, LA. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. J Parkinsons Dis. 2011;1 (1):119-22. doi: 10.3233/JPD-2011-11006. PubMed PMID:23939262 .
  100. Aasly, JO, Vilariño-Güell, C, Dachsel, JC, Webber, PJ, West, AB, Haugarvoll, K, Johansen, KK, Toft, M, Nutt, JG, Payami, H, Kachergus, JM, Lincoln, SJ, Felic, A, Wider, C, Soto-Ortolaza, AI, Cobb, SA, White, LR, Ross, OA, Farrer, MJ. Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease. Mov. Disord. 2010;25 (13):2156-63. doi: 10.1002/mds.23265. PubMed PMID:20669305 PubMed Central PMC2970614.
  101. Tzoulis, C, Neckelmann, G, Mørk, SJ, Engelsen, BE, Viscomi, C, Moen, G, Ersland, L, Zeviani, M, Bindoff, LA. Localized cerebral energy failure in DNA polymerase gamma-associated encephalopathy syndromes. Brain. 2010;133 (Pt 5):1428-37. doi: 10.1093/brain/awq067. PubMed PMID:20400524 .
  102. Lau, C, Dölle, C, Gossmann, TI, Agledal, L, Niere, M, Ziegler, M. Isoform-specific targeting and interaction domains in human nicotinamide mononucleotide adenylyltransferases. J. Biol. Chem. 2010;285 (24):18868-76. doi: 10.1074/jbc.M110.107631. PubMed PMID:20388704 PubMed Central PMC2881809.
  103. Sanaker, PS, Toompuu, M, Hogan, VE, He, L, Tzoulis, C, Chrzanowska-Lightowlers, ZM, Taylor, RW, Bindoff, LA. Differences in RNA processing underlie the tissue specific phenotype of ISCU myopathy. Biochim. Biophys. Acta. 2010;1802 (6):539-44. doi: 10.1016/j.bbadis.2010.02.010. PubMed PMID:20206689 .
  104. Haugarvoll, K, Wszolek, ZK. Clinical features of LRRK2 parkinsonism. Parkinsonism Relat. Disord. 2009;15 Suppl 3 :S205-8. doi: 10.1016/S1353-8020(09)70815-6. PubMed PMID:20082991 .
  105. Dölle, C, Niere, M, Lohndal, E, Ziegler, M. Visualization of subcellular NAD pools and intra-organellar protein localization by poly-ADP-ribose formation. Cell. Mol. Life Sci. 2010;67 (3):433-43. doi: 10.1007/s00018-009-0190-4. PubMed PMID:19902144 .
  106. Pascual-García, A, Abia, D, Méndez, R, Nido, GS, Bastolla, U. Quantifying the evolutionary divergence of protein structures: the role of function change and function conservation. Proteins. 2010;78 (1):181-96. doi: 10.1002/prot.22616. PubMed PMID:19830831 .
  107. Gramstad, A, Bindoff, LA, Lillebø, A, Tzoulis, C, Engelsen, BA. Neuropsychological performance in patients with POLG1 mutations and the syndrome of mitochondrial spinocerebellar ataxia and epilepsy. Epilepsy Behav. 2009;16 (1):172-4. doi: 10.1016/j.yebeh.2009.01.014. PubMed PMID:19435586 .
  108. Wider, C, Lincoln, SJ, Heckman, MG, Diehl, NN, Stone, JT, Haugarvoll, K, Aasly, JO, Gibson, JM, Lynch, T, Rajput, A, Rajput, ML, Uitti, RJ, Wszolek, ZK, Farrer, MJ, Ross, OA. Phactr2 and Parkinson's disease. Neurosci. Lett. 2009;453 (1):9-11. doi: 10.1016/j.neulet.2009.02.009. PubMed PMID:19429005 PubMed Central PMC2684848.
  109. Vilariño-Güell, C, Ross, OA, Soto, AI, Farrer, MJ, Haugarvoll, K, Aasly, JO, Uitti, RJ, Wszolek, ZK. Reported mutations in GIGYF2 are not a common cause of Parkinson's disease. Mov. Disord. 2009;24 (4):619-20. doi: 10.1002/mds.22451. PubMed PMID:19133664 .
  110. Wider, C, Dachsel, JC, Soto, AI, Heckman, MG, Diehl, NN, Yue, M, Lincoln, S, Aasly, JO, Haugarvoll, K, Trojanowski, JQ, Papapetropoulos, S, Mash, D, Rajput, A, Rajput, AH, Gibson, JM, Lynch, T, Dickson, DW, Uitti, RJ, Wszolek, ZK, Farrer, MJ, Ross, OA. FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression. Mov. Disord. 2009;24 (3):455-9. doi: 10.1002/mds.22442. PubMed PMID:19133659 PubMed Central PMC2875476.
  111. Tzoulis, C, Bindoff, LA. Serial diffusion imaging in a case of mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Stroke. 2009;40 (2):e15-7. doi: 10.1161/STROKEAHA.108.523118. PubMed PMID:19095975 .
  112. Dölle, C, Ziegler, M. Application of a coupled enzyme assay to characterize nicotinamide riboside kinases. Anal. Biochem. 2009;385 (2):377-9. doi: 10.1016/j.ab.2008.10.033. PubMed PMID:19027704 .
  113. Ross, OA, Spanaki, C, Griffith, A, Lin, CH, Kachergus, J, Haugarvoll, K, Latsoudis, H, Plaitakis, A, Ferreira, JJ, Sampaio, C, Bonifati, V, Wu, RM, Zabetian, CP, Farrer, MJ. Haplotype analysis of Lrrk2 R1441H carriers with parkinsonism. Parkinsonism Relat. Disord. 2009;15 (6):466-7. doi: 10.1016/j.parkreldis.2008.09.001. PubMed PMID:18952485 PubMed Central PMC2749264.
  114. Haugarvoll, K, Toft, M, Skipper, L, Heckman, MG, Crook, JE, Soto, A, Ross, OA, Hulihan, MM, Kachergus, JM, Sando, SB, White, LR, Lynch, T, Gibson, JM, Uitti, RJ, Wszolek, ZK, Aasly, JO, Farrer, MJ. Fine-mapping and candidate gene investigation within the PARK10 locus. Eur. J. Hum. Genet. 2009;17 (3):336-43. doi: 10.1038/ejhg.2008.187. PubMed PMID:18854859 PubMed Central PMC2986168.
  115. Ross, OA, Heckman, MG, Soto, AI, Diehl, NN, Haugarvoll, K, Vilariño-Güell, C, Aasly, JO, Sando, S, Gibson, JM, Lynch, T, Krygowska-Wajs, A, Opala, G, Barcikowska, M, Czyzewski, K, Uitti, RJ, Wszolek, ZK, Farrer, MJ. Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease. Parkinsonism Relat. Disord. 2008;14 (7):544-7. doi: 10.1016/j.parkreldis.2008.07.002. PubMed PMID:18722802 PubMed Central PMC2592561.
  116. Ross, OA, Toft, M, Haugarvoll, K. Corticobasal syndrome and primary progressive aphasia as manifestations of lrrk2 gene mutations. Neurology. 2008;71 (4):303; author reply 303-4. doi: 10.1212/01.wnl.0000320511.30222.dd. PubMed PMID:18645174 .
  117. Tzoulis, C, Denora, PS, Santorelli, FM, Bindoff, LA. Hereditary spastic paraplegia caused by the novel mutation 1047insC in the SPG7 gene. J. Neurol. 2008;255 (8):1142-4. doi: 10.1007/s00415-008-0858-y. PubMed PMID:18563470 .
  118. Tzoulis, C, Bindoff, LA. Melas associated with mutations in the polg1 gene. Neurology. 2008;70 (13):1054; author reply 1054-5. doi: 10.1212/01.wnl.0000307661.98694.c3. PubMed PMID:18362288 .
  119. Engelsen, BA, Tzoulis, C, Karlsen, B, Lillebø, A, Laegreid, LM, Aasly, J, Zeviani, M, Bindoff, LA. POLG1 mutations cause a syndromic epilepsy with occipital lobe predilection. Brain. 2008;131 (Pt 3):818-28. doi: 10.1093/brain/awn007. PubMed PMID:18238797 .
  120. Haugarvoll, K, Wszolek, ZK, Hutton, M. The genetics of frontotemporal dementia. Neurol Clin. 2007;25 (3):697-715, vi. doi: 10.1016/j.ncl.2007.03.002. PubMed PMID:17659186 .
  121. Ross, OA, Haugarvoll, K, Stone, JT, Heckman, MG, White, LR, Aasly, JO, Mark Gibson, J, Lynch, T, Wszolek, ZK, Uitti, RJ, Farrer, MJ. Lack of evidence for association of Parkin promoter polymorphism (PRKN-258) with increased risk of Parkinson's disease. Parkinsonism Relat. Disord. 2007;13 (7):386-8. doi: 10.1016/j.parkreldis.2007.01.010. PubMed PMID:17400506 PubMed Central PMC4381345.
  122. Haugarvoll, K, Toft, M, Ross, OA, White, LR, Aasly, JO, Farrer, MJ. Variants in the LRRK1 gene and susceptibility to Parkinson's disease in Norway. Neurosci. Lett. 2007;416 (3):299-301. doi: 10.1016/j.neulet.2007.02.020. PubMed PMID:17324517 .
  123. Pollak, N, Dölle, C, Ziegler, M. The power to reduce: pyridine nucleotides--small molecules with a multitude of functions. Biochem. J. 2007;402 (2):205-18. doi: 10.1042/BJ20061638. PubMed PMID:17295611 PubMed Central PMC1798440.
  124. Haugarvoll, K, Toft, M, Ross, OA, Stone, JT, Heckman, MG, White, LR, Lynch, T, Gibson, JM, Wszolek, ZK, Uitti, RJ, Aasly, JO, Farrer, MJ. ELAVL4, PARK10, and the Celts. Mov. Disord. 2007;22 (4):585-7. doi: 10.1002/mds.21336. PubMed PMID:17230446 .
  125. Farrer, MJ, Stone, JT, Lin, CH, Dächsel, JC, Hulihan, MM, Haugarvoll, K, Ross, OA, Wu, RM. Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia. Parkinsonism Relat. Disord. 2007;13 (2):89-92. doi: 10.1016/j.parkreldis.2006.12.001. PubMed PMID:17222580 .
  126. Toft, M, Mata, IF, Ross, OA, Kachergus, J, Hulihan, MM, Haugarvoll, K, Stone, JT, Blazquez, M, Gibson, JM, Aasly, JO, White, LR, Lynch, T, Adler, CH, Gwinn-Hardy, K, Farrer, MJ. Pathogenicity of the Lrrk2 R1514Q substitution in Parkinson's disease. Mov. Disord. 2007;22 (3):389-92. doi: 10.1002/mds.21217. PubMed PMID:17216639 .
  127. Gosal, D, Lynch, T, Ross, OA, Haugarvoll, K, Farrer, MJ, Gibson, JM. Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred. Mov. Disord. 2007;22 (2):291-2. doi: 10.1002/mds.21200. PubMed PMID:17089395 .
  128. Haugarvoll, K, Uitti, RJ, Farrer, MJ, Wszolek, ZK. LRRK2 gene and tremor-dominant parkinsonism. Arch. Neurol. 2006;63 (9):1346-7. doi: 10.1001/archneur.63.9.1346-b. PubMed PMID:16966525 .
  129. Sanaker, PS, Aarhus, M, Lund-Johansen, M, Smievoll, AI, Tzoulis, C, Skeie, GO. [A 90-year-old woman with acute hemiparesis]. Tidsskr. Nor. Laegeforen. 2006;126 (15):1931-3. . PubMed PMID:16937574 .
  130. Haugarvoll, K, Wszolek, ZK. PARK8 LRRK2 parkinsonism. Curr Neurol Neurosci Rep. 2006;6 (4):287-94. doi: 10.1007/s11910-006-0020-0. PubMed PMID:16822348 .
  131. Farrer, MJ, Haugarvoll, K, Ross, OA, Stone, JT, Milkovic, NM, Cobb, SA, Whittle, AJ, Lincoln, SJ, Hulihan, MM, Heckman, MG, White, LR, Aasly, JO, Gibson, JM, Gosal, D, Lynch, T, Wszolek, ZK, Uitti, RJ, Toft, M. Genomewide association, Parkinson disease, and PARK10. Am. J. Hum. Genet. 2006;78 (6):1084-8; author reply 1092-4. doi: 10.1086/504728. PubMed PMID:16685661 PubMed Central PMC1474105.
  132. Tzoulis, C, Engelsen, BA, Telstad, W, Aasly, J, Zeviani, M, Winterthun, S, Ferrari, G, Aarseth, JH, Bindoff, LA. The spectrum of clinical disease caused by the A467T and W748S POLG mutations: a study of 26 cases. Brain. 2006;129 (Pt 7):1685-92. doi: 10.1093/brain/awl097. PubMed PMID:16638794 .
Search PubMed